Related Experiment Video
Updated: May 25, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
CyberKnife radiosurgery for brain metastases.
Berndt Wowra1, Alexander Muacevic, Jörg-Christian Tonn
1European CyberKnife Center Munich-Grosshadern, University of Munich, Munich, Germany. Berndt.Wowra@cyber-knife.net
Progress in Neurological Surgery
|January 13, 2012
Summary
The CyberKnife, a frameless robotic radiosurgery system, offers effective non-invasive treatment for brain metastases, matching traditional methods. Its full-body capability and repeatability make it a valuable tool in oncology.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Technology
Background:
- Classic radiosurgery uses frame-based systems for single-fraction irradiation of brain lesions.
- The CyberKnife, introduced in 1997, is an image-guided, frameless robotic system for whole-body radiosurgery.
- Brain metastases are a common indication for modern radiosurgery.
Purpose of the Study:
- To review data on CyberKnife radiosurgery for brain metastases.
- To compare CyberKnife's intracranial treatment quality with frame-based technologies.
- To evaluate the clinical significance of hypofractionated CyberKnife treatments and its use in resection cavities.
Main Methods:
- Review of scientific data on CyberKnife radiosurgery for brain metastases.
- Comparison of CyberKnife's intracranial treatment quality against frame-based systems.
- Analysis of clinical outcomes, including tumor control, toxicity, and repeatability.
Main Results:
- CyberKnife demonstrates comparable intracranial treatment quality to frame-based technologies.
- Clinical results for single-fraction CyberKnife radiosurgery align with existing literature.
- High tumor control and low toxicity are observed, with successful retreatment for recurrent metastases.
Conclusions:
- CyberKnife is a modern, non-invasive technology for intra- and extracranial radiosurgery.
- It offers a high tumor control and low toxicity profile for brain metastases.
- Further research is needed to clarify the clinical significance of hypofractionated treatments and radiosurgery in resection cavities.
